| pubmed-article:21036034 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21036034 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:21036034 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:21036034 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:21036034 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
| pubmed-article:21036034 | pubmed:issue | 18 | lld:pubmed |
| pubmed-article:21036034 | pubmed:dateCreated | 2010-11-29 | lld:pubmed |
| pubmed-article:21036034 | pubmed:abstractText | The United Kingdom is currently moving the age limit for invitation in its national breast screening programme downwards from 50 to 47. In contrast, the US Preventive Services Task Force concluded that, because of borderline statistical significance on effectiveness of mammographic screening, the current evidence is insufficient to advise screening in women aged 40-49. | lld:pubmed |
| pubmed-article:21036034 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21036034 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21036034 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21036034 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21036034 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:21036034 | pubmed:issn | 1879-0852 | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:VerbeekAndré... | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:den... | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:DondersRogier... | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:HollandRoland... | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:OttenJohannes... | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:BroedersMirei... | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:MossSue MSM | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:21036034 | pubmed:author | pubmed-author:PaapEllenE | lld:pubmed |
| pubmed-article:21036034 | pubmed:copyrightInfo | Copyright © 2010 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:21036034 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21036034 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:21036034 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21036034 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21036034 | pubmed:pagination | 3137-40 | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:meshHeading | pubmed-meshheading:21036034... | lld:pubmed |
| pubmed-article:21036034 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:21036034 | pubmed:articleTitle | Effective biennial mammographic screening in women aged 40-49. | lld:pubmed |
| pubmed-article:21036034 | pubmed:affiliation | Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. g.vanschoor@ebh.umcn.nl | lld:pubmed |
| pubmed-article:21036034 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21036034 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21036034 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
